Search Within

Gary Schwartz

Formats
  1. Journal Article (191)
  2. Meeting Abstract (190)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (215)
  2. Solid Tumor Oncology Division (205)
  3. Melanoma Disease Management Team (129)
  4. Center for Pancreatic Cancer Research (99)
  5. Gastrointestinal Oncology Service (99)
  6. GSK Faculty (91)

More Groups

People
  1. David Kelsen (79)
  2. Richard Carvajal (61)
  3. Manish Shah (41)
  4. Mark Dickson (40)
  5. Eileen O'Reilly (36)
  6. Monica Motwani (36)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (2)
  4. 2016 (3)
  5. 2015 (5)
  6. 2014 (23)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Cancer Research (42)
  3. Clinical Cancer Research (39)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (30)
  5. Annals of Oncology (12)
  6. Cancer (12)

More Publications

Publishers
  1. American Association for Cancer Research (121)
  2. American Society of Clinical Oncology (105)
  3. Elsevier Inc. (20)
  4. Springer (20)
  5. Oxford University Press (16)
  6. Wiley Blackwell (15)

More Publishers

Results (385)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radical surgery as local therapy for stage IV rectal cancer: Treatment results
    Meeting Abstract

    Nash, G. M.; Saltz, L.; Sharma, S.; Kemeny, N.; Schwartz, G.; Ilson, D.; O'reilly, E.; Kelsen, D.; Minsky, B.; Nathanson, D. R.; more...
    Annals of Surgical Oncology (2002)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of LY293111, an orally available small molecule known to be an LTB4 receptor antagonist, 5-lipoxygenase inhibitor and peroxisome proliferator activated receptor-gamma agonist (PPAR gamma)
    Meeting Abstract

    Budman, D. R.; Schwartz, G. K.; Endres, S.; Welch, M.; O'reilly, E.; Barile-Thiem, B.; Brail, L. H.; De Alwis, D. P.; Cleverly, A.; Weitzman, A.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • A phase I/II study of DX-8951f and gemcitabine in advanced solid tumour malignancies
    Meeting Abstract

    Abou-Alfa, G.; Lenzi, R.; Mani, S.; Schwartz, G.; Maki, R.; Kelsen, D.; Levin, A.; Ackerman, J.; DeJager, R.; O'reilly, E.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • CDK inhibitors: Cell cycle arrest versus apoptosis
    Journal Article

    Schwartz, G. K.
    Cell Cycle (2002)

    Fulltext@MSK | Save
  • Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors
    Journal Article

    Schwartz, G. K.; O'reilly, E.; Ilson, D.; Saltz, L.; Sharma, S.; Tong, W.; Maslak, P.; Stoltz, M.; Eden, L.; Perkins, P.; more...
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Journal Article

    Pfister, D. G.; McCaffrey, J.; Zahalsky, A. J.; Schwartz, G. K.; Lis, E.; Gerald, W.; Huvos, A.; Shah, J.; Kraus, D.; Shaha, A.; more...
    Investigational New Drugs (2002)

    Fulltext@MSK | Save
  • Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease
    Journal Article

    Nash, G. M.; Saltz, L. B.; Kemeny, N. E.; Minsky, B.; Sharma, S.; Schwartz, G. K.; Ilson, D. H.; O'reilly, E.; Kelsen, D. P.; Nathanson, D. R.; more...
    Annals of Surgical Oncology (2002)

    Fulltext@MSK | Save
  • Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells
    Journal Article

    Motwani, M.; Sirotnak, F. M.; She, Y.; Commes, T.; Schwartz, G. K.
    Cancer Research (2002)

    Fulltext@MSK | Save
  • Augmentation in response and cure rate by flavopiridol (FP) in CPT-11 treated colon cancer xenografts
    Meeting Abstract

    Motwani, M. V.; Jung, C.; Sirotnak, F. M.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • 9-nitropaullone (9-NP), a CDK1 inhibitor, enhances chemotherapy induced apoptosis in a sequential dependent manner
    Meeting Abstract

    Little, A.; Motwani, M. V.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save